Smoking Cessation

Needs Statement

Tobacco use can result in tobacco use disorders and serious health complications. By implementing medication and behavioral interventions, providers can increase patient success with smoking cessation and improve overall health outcomes. This presentation will address behavioral and medical treatment components for smoking cessation in primary care. This course is designed for medical and behavioral professionals working within a primary care setting.

Educational Objectives

At the conclusion of this activity, the participant should be able to:

• Determine effective behavioral modification tools and medication interventions for smoking cessation.
• Discuss motivational interviewing skills for smoking cessation, including: empathy, reflective listening, affirmations, developing discrepancy, and avoiding argumentation.
• Outline the pharmacotherapy for smoking cessation plan including monitoring for safety and efficacy.
• Implement motivational interviewing in patient counseling to increase patient engagement and success in smoking cessation goals.

Target Audience

Accreditation/Credit Designation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Baylor College of Medicine and Legacy Community Health. Baylor College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Baylor College of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Policy

Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.

In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.

In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.

BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.

All of the relevant financial relationships listed for these individuals have been mitigated.